10:26 AM EDT, 03/24/2025 (MT Newswires) -- Novo Nordisk ( NVO ) secured exclusive global rights to United Laboratories International's therapeutic candidate for obesity and type 2 diabetes in a licensing deal worth up to $2 billion. The product called UBT251 targets the receptors for glucagon-like peptide-1, or GLP-1, glucose-dependent insulinotropic polypeptide, or GIP, and glucagon. The drug is currently...

10:24 AM EDT, 03/24/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Monday it will now allow cash-paying patients access to Wegovy injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg at local pharmacies for a reduced cost of $499 per month following updates to its Wegovy savings program. The $499-per-month offer for Wegovy was only...

10:24 AM EDT, 03/24/2025 (MT Newswires) -- Dun & Bradstreet ( DNB ) agreed to be acquired by Clearlake Capital Group in a deal with a $7.7 billion transaction value that includes debt, sending shares of the business data and analytics firm higher Monday. The sale will see investors in Dun & Bradstreet ( DNB ) receive $9.15 a share...

10:27 AM EDT, 03/24/2025 (MT Newswires) -- China's BYD reported 2024 operating revenue Monday of 777.10 billion Chinese renminbi ($107.20 billion), up from 602.32 billion renminbi in 2023 and beating Tesla's (TSLA) $97.69 billion revenue for the same year. Analysts polled by FactSet estimated BYD's 2024 revenue at 767.67 billion renminbi. BYD's 2024 net profit also increased to 40.25 billion...